Integrated DNA Technologies Meets Increasing Biotech & Life Science Research Demands With New Operating Hours; Expanded Hours Benefit DNA and RNA Sequencing Houses and Researchers Coast-to-Coast.

CORALVILLE, Iowa -- Integrated DNA Technologies is responding to the evolving needs of its biotech customers by extending the operating schedule at its main oligonucleotide production center effective immediately. The new schedule (7:30am to 10:00pm CT) enables biotech researchers to order their products later each day, and still receive the benefits of IDT's swift order fulfillment process. The new schedule also better serves the needs of sequencing houses and bio-science research labs by expanding the availability of IDT's live support and product ordering experts.

Combined with extensive online ordering options, including free oligo design and analysis software, IDT's enhanced service operations and support hours give scientists the technical assistance they need, whether placing, following up, or seeking guidance on orders. The new service options are in line with IDT's ongoing commitment to quality and turnaround, which includes benefits such as:

--Every oligo synthesized is quality control tested by mass spectrometry.

--The use of high-throughput advanced ESI Mass Spec technology allows greater quality control (QC) of oligos at any length.

--Purified oligos receive additional QC by capillary electrophoresis.

--Access to all quality control documents available free on the web.

--All oligos are twice quantitated by UV spectrophotometry 

"Our new operating hours give researchers better options," noted Trey Martin, COO of Integrated DNA Technologies. "We listened to the marketplace, and responded with improvements that reflect the pressures and demands on today's research labs."

For more information visit http://www.idtdna.com

About IDT 

Integrated DNA Technologies, Inc. (IDT) is the largest supplier of custom nucleic acids in the U.S., serving the areas of academic research, biotechnology, and pharmaceutical development. IDT's primary business is the manufacturing of DNA and RNA oligonucleotides (oligos) for research applications.

Founded in 1987 by Joseph Walder, M.D., Ph.D. (University of Iowa), Integrated DNA Technologies, Inc. has grown an average of over 50% every year during the past 10 years. Now IDT synthesizes and ships 15,000 to 25,000 oligos per day, and more than 60,000 customers worldwide turn to IDT to fulfill their oligo requirements.